Cargando…
Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge
Stress testing is challenging in patients with chronic obstructive pulmonary disease (COPD). Functional capacity is generally decreased in this patient population, limiting patients’ ability to achieve physiologic stress through exercise. Additionally, due to emphysematous changes, COPD patients ten...
Autores principales: | Golzar, Yasmeen, Doukky, Rami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904829/ https://www.ncbi.nlm.nih.gov/pubmed/24489466 http://dx.doi.org/10.2147/COPD.S56879 |
Ejemplares similares
-
Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008) -
A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease
por: Prenner, Bruce M., et al.
Publicado: (2012) -
Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014) -
Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013) -
Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease
por: Lopez-Campos, José Luis, et al.
Publicado: (2020)